Scientific and Medical Equipment House Company (TADAWUL: 4014)
Saudi Arabia
· Delayed Price · Currency is SAR 50.30
-0.80 (-1.57%)
Dec 19, 2024, 3:16 PM AST
Scientific and Medical Equipment House Company Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 902.58 | 799.28 | 713.82 | 699.45 | 617.47 | 597.02 | Upgrade
|
| Revenue Growth (YoY) | 22.70% | 11.97% | 2.05% | 13.28% | 3.43% | 2.24% | Upgrade
|
| Cost of Revenue | 755.5 | 666.77 | 560.04 | 546.7 | 467.03 | 463.62 | Upgrade
|
| Gross Profit | 147.09 | 132.51 | 153.78 | 152.75 | 150.45 | 133.4 | Upgrade
|
| Selling, General & Admin | 94.81 | 87.89 | 78.18 | 65.89 | 63.62 | 67.03 | Upgrade
|
| Operating Expenses | 79.23 | 66.38 | 117.61 | 70.36 | 63.62 | 67.03 | Upgrade
|
| Operating Income | 67.86 | 66.13 | 36.17 | 82.39 | 86.83 | 66.37 | Upgrade
|
| Interest Expense | -29.88 | -25.29 | -19.65 | -12.95 | -12.55 | -19.46 | Upgrade
|
| Interest & Investment Income | - | - | 0.05 | 0.33 | 0.35 | 0.36 | Upgrade
|
| Other Non Operating Income (Expenses) | 17.92 | 12.09 | 11.08 | 14.84 | 6.69 | 23.48 | Upgrade
|
| EBT Excluding Unusual Items | 55.89 | 52.93 | 27.65 | 84.62 | 81.32 | 70.75 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.23 | 0.02 | 0.09 | 0.22 | 0.23 | -0.02 | Upgrade
|
| Pretax Income | 56.12 | 52.95 | 27.74 | 84.83 | 81.55 | 70.73 | Upgrade
|
| Income Tax Expense | 15.29 | 15.15 | 12.12 | 8.09 | 7.39 | 0.33 | Upgrade
|
| Earnings From Continuing Operations | 40.83 | 37.8 | 15.62 | 76.75 | 74.16 | 70.41 | Upgrade
|
| Minority Interest in Earnings | 1.48 | 2.26 | 1.95 | 0.78 | 0.6 | 0.26 | Upgrade
|
| Net Income | 40.93 | 40.06 | 17.57 | 77.52 | 74.76 | 70.67 | Upgrade
|
| Net Income to Common | 40.93 | 40.06 | 17.57 | 77.52 | 74.76 | 70.67 | Upgrade
|
| Net Income Growth | 3417.97% | 128.04% | -77.34% | 3.70% | 5.79% | 3.81% | Upgrade
|
| Shares Outstanding (Basic) | 30 | 30 | 30 | 30 | 30 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 30 | 30 | 30 | 30 | 30 | Upgrade
|
| EPS (Basic) | 1.36 | 1.34 | 0.59 | 2.58 | 2.49 | 2.36 | Upgrade
|
| EPS (Diluted) | 1.36 | 1.34 | 0.59 | 2.58 | 2.49 | 2.36 | Upgrade
|
| EPS Growth | 3418.00% | 128.04% | -77.34% | 3.70% | 5.79% | 3.81% | Upgrade
|
| Free Cash Flow | 246.02 | -155.51 | 133.46 | -79.49 | 94.34 | 152.29 | Upgrade
|
| Free Cash Flow Per Share | 8.20 | -5.18 | 4.45 | -2.65 | 3.14 | 5.08 | Upgrade
|
| Dividend Per Share | 1.000 | 1.000 | - | 0.667 | 1.000 | - | Upgrade
|
| Dividend Growth | - | - | - | -33.33% | - | - | Upgrade
|
| Gross Margin | 16.30% | 16.58% | 21.54% | 21.84% | 24.37% | 22.34% | Upgrade
|
| Operating Margin | 7.52% | 8.27% | 5.07% | 11.78% | 14.06% | 11.12% | Upgrade
|
| Profit Margin | 4.53% | 5.01% | 2.46% | 11.08% | 12.11% | 11.84% | Upgrade
|
| Free Cash Flow Margin | 27.26% | -19.46% | 18.70% | -11.36% | 15.28% | 25.51% | Upgrade
|
| EBITDA | 79.52 | 79.11 | 47.73 | 91.47 | 93.14 | 70.3 | Upgrade
|
| EBITDA Margin | 8.81% | 9.90% | 6.69% | 13.08% | 15.08% | 11.77% | Upgrade
|
| D&A For EBITDA | 11.66 | 12.98 | 11.56 | 9.08 | 6.31 | 3.93 | Upgrade
|
| EBIT | 67.86 | 66.13 | 36.17 | 82.39 | 86.83 | 66.37 | Upgrade
|
| EBIT Margin | 7.52% | 8.27% | 5.07% | 11.78% | 14.06% | 11.12% | Upgrade
|
| Effective Tax Rate | 27.24% | 28.61% | 43.70% | 9.53% | 9.07% | 0.46% | Upgrade
|
| Advertising Expenses | - | 0.14 | 0.27 | 0.22 | 0.07 | 0.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.